|
1
|
Comparison of corneal thickness measurements using Galilei, HR Pentacam, and ultrasound.
|
Cornea
|
2010
|
1.04
|
|
2
|
Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
|
Retina
|
2009
|
0.95
|
|
3
|
Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia.
|
Med Hypotheses
|
2007
|
0.94
|
|
4
|
Bilateral spontaneous rupture of posterior capsule in posterior polar cataract.
|
Clin Experiment Ophthalmol
|
2008
|
0.94
|
|
5
|
Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
|
Retina
|
2012
|
0.93
|
|
6
|
Cone location and correction of keratoconus with rigid gas-permeable contact lenses.
|
Cont Lens Anterior Eye
|
2011
|
0.89
|
|
7
|
Effect of anterior chamber air bubble on prevention of experimental Staphylococcus epidermidis endophthalmitis.
|
Graefes Arch Clin Exp Ophthalmol
|
2009
|
0.81
|
|
8
|
Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).
|
Med Hypotheses
|
2007
|
0.77
|
|
9
|
Debate on the various anti-vascular endothelial growth factor drugs.
|
Indian J Ophthalmol
|
2008
|
0.75
|